Oppenheimer & CO Inc Jazz Pharmaceuticals PLC Transaction History

Oppenheimer & CO Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$129.72 - $159.85 $28,278 - $34,847	-218 Reduced 13.49%	1,398 $222,000
Q3 2022 Nov 14, 2022	SELL	$126.59 - $161.18 $42,787 - $54,478	-338 Reduced 17.3%	1,616 $215,000
Q4 2021 Feb 02, 2022	SELL	$119.87 - $145.67 $2,037 - $2,476	-17 Reduced 0.86%	1,954 $249,000
Q3 2021 Nov 12, 2021	SELL	$128.64 - $184.79 $7,589 - $10,902	-59 Reduced 2.91%	1,971 $257,000
Q2 2021 Aug 03, 2021	BUY	$160.2 - $186.42 $15,058 - $17,523	94 Added 4.86%	2,030 $361,000
Q1 2021 May 10, 2021	SELL	$150.19 - $173.5 $9,762 - $11,277	-65 Reduced 3.25%	1,936 $318,000
Q3 2020 Nov 13, 2020	SELL	$105.46 - $144.13 $19,826 - $27,096	-188 Reduced 8.59%	2,001 $285,000
Q2 2020 Aug 11, 2020	SELL	$95.68 - $121.88 $45,735 - $58,258	-478 Reduced 17.92%	2,189 $242,000
Q1 2020 May 08, 2020	BUY	$87.74 - $152.74 $234,002 - $407,357	2,667 New	2,667 $266,000

512

57.5M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Oppenheimer & CO Inc with notifications on news.